Disruption of PDGFRα-initiated PI3K activation and migration of somite derivatives leads to spina bifida
Open Access
- 1 February 2008
- journal article
- Published by The Company of Biologists in Development
- Vol. 135 (3) , 589-598
Abstract
Spina bifida, or failure of the vertebrae to close at the midline, is a common congenital malformation in humans that is often synonymous with neural tube defects (NTDs). However, it is likely that other etiologies exist. Genetic disruption of platelet-derived growth factor receptor (PDGFR) αresults in spina bifida, but the underlying mechanism has not been identified. To elucidate the cause of this birth defect in PDGFRα mutant embryos, we examined the developmental processes involved in vertebrae formation. Exposure of chick embryos to the PDGFR inhibitor imatinib mesylate resulted in spina bifida in the absence of NTDs. We next examined embryos with a tissue-specific deletion of the receptor. We found that loss of the receptor from chondrocytes did not recapitulate the spina bifida phenotype. By contrast, loss of the receptor from all sclerotome and dermatome derivatives or disruption of PDGFRα-driven phosphatidyl-inositol 3′ kinase (PI3K) activity resulted in spina bifida. Furthermore, we identified a migration defect in the sclerotome as the cause of the abnormal vertebral development. We found that primary cells from these mice exhibited defects in PAK1 activation and paxillin localization. Taken together, these results indicate that PDGFRα downstream effectors, especially PI3K, are essential for cell migration of a somite-derived dorsal mesenchyme and disruption of receptor signaling in these cells leads to spina bifida.Keywords
This publication has 80 references indexed in Scilit:
- FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopodDevelopmental Biology, 2007
- Cooperation between the PDGF receptors in cardiac neural crest cell migrationDevelopmental Biology, 2007
- DefectiveN-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular developmentGenes & Development, 2007
- Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AMLBlood, 2006
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006
- Paxillin phosphorylation at Ser273 localizes a GIT1–PIX–PAK complex and regulates adhesion and protrusion dynamicsJournal of Cell Biology, 2006
- Distinct mechanisms regulate hemocyte chemotaxis during development and wound healing in Drosophila melanogaster Journal of Cell Biology, 2006
- Formation and differentiation of the avian sclerotomeBrain Structure and Function, 2004
- Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell DevelopmentPLOS Biology, 2003
- Pharmacology of imatinib (STI571)European Journal of Cancer, 2002